Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cervical cancer
|
268 | 0.476 | 0.800 | 3 | 9757089 | missense variant | C/G | snv | 0.27 | 0.22 | 0.020 | 1.000 | 2 | 2005 | 2019 | ||||
Cervix carcinoma
|
283 | 0.476 | 0.800 | 3 | 9757089 | missense variant | C/G | snv | 0.27 | 0.22 | 0.020 | 1.000 | 2 | 2005 | 2019 | ||||
Malignant tumor of cervix
|
245 | 0.476 | 0.800 | 3 | 9757089 | missense variant | C/G | snv | 0.27 | 0.22 | 0.020 | 1.000 | 2 | 2005 | 2019 | ||||
Adenoma
|
103 | 0.476 | 0.800 | 3 | 9757089 | missense variant | C/G | snv | 0.27 | 0.22 | 0.010 | 1 | 2005 | 2005 | |||||
Adenoma of large intestine
|
213 | 0.476 | 0.800 | 3 | 9757089 | missense variant | C/G | snv | 0.27 | 0.22 | 0.010 | 1.000 | 1 | 2005 | 2005 | ||||
Liver carcinoma
|
942 | 0.476 | 0.800 | 3 | 9757089 | missense variant | C/G | snv | 0.27 | 0.22 | 0.070 | 1.000 | 7 | 2006 | 2019 | ||||
Non-Small Cell Lung Carcinoma
|
712 | 0.476 | 0.800 | 3 | 9757089 | missense variant | C/G | snv | 0.27 | 0.22 | 0.050 | 1.000 | 5 | 2006 | 2019 | ||||
Xeroderma Pigmentosum, Complementation Group D
|
111 | 0.476 | 0.800 | 3 | 9757089 | missense variant | C/G | snv | 0.27 | 0.22 | 0.050 | 1.000 | 5 | 2006 | 2013 | ||||
Squamous cell carcinoma of the head and neck
|
348 | 0.476 | 0.800 | 3 | 9757089 | missense variant | C/G | snv | 0.27 | 0.22 | 0.040 | 1.000 | 4 | 2006 | 2018 | ||||
Adenocarcinoma
|
168 | 0.476 | 0.800 | 3 | 9757089 | missense variant | C/G | snv | 0.27 | 0.22 | 0.010 | 1.000 | 1 | 2006 | 2006 | ||||
Hepatocarcinogenesis
|
24 | 0.476 | 0.800 | 3 | 9757089 | missense variant | C/G | snv | 0.27 | 0.22 | 0.010 | 1 | 2006 | 2006 | |||||
Myocardial Ischemia
|
103 | 0.476 | 0.800 | 3 | 9757089 | missense variant | C/G | snv | 0.27 | 0.22 | 0.010 | 1.000 | 1 | 2006 | 2006 | ||||
Tooth Loss
|
8 | 0.476 | 0.800 | 3 | 9757089 | missense variant | C/G | snv | 0.27 | 0.22 | 0.010 | 1.000 | 1 | 2006 | 2006 | ||||
Bladder Neoplasm
|
281 | 0.476 | 0.800 | 3 | 9757089 | missense variant | C/G | snv | 0.27 | 0.22 | 0.070 | 0.857 | 7 | 2007 | 2014 | ||||
Carcinoma of bladder
|
309 | 0.476 | 0.800 | 3 | 9757089 | missense variant | C/G | snv | 0.27 | 0.22 | 0.070 | 0.857 | 7 | 2007 | 2014 | ||||
Malignant neoplasm of urinary bladder
|
316 | 0.476 | 0.800 | 3 | 9757089 | missense variant | C/G | snv | 0.27 | 0.22 | 0.070 | 0.857 | 7 | 2007 | 2014 | ||||
Alzheimer's Disease
|
1843 | 0.476 | 0.800 | 3 | 9757089 | missense variant | C/G | snv | 0.27 | 0.22 | 0.060 | 1.000 | 6 | 2007 | 2019 | ||||
Gallbladder Carcinoma
|
75 | 0.476 | 0.800 | 3 | 9757089 | missense variant | C/G | snv | 0.27 | 0.22 | 0.020 | 1.000 | 2 | 2007 | 2009 | ||||
Malignant neoplasm of gallbladder
|
81 | 0.476 | 0.800 | 3 | 9757089 | missense variant | C/G | snv | 0.27 | 0.22 | 0.020 | 1.000 | 2 | 2007 | 2009 | ||||
Neoplasms
|
1644 | 0.476 | 0.800 | 3 | 9757089 | missense variant | C/G | snv | 0.27 | 0.22 | 0.020 | 0.500 | 2 | 2007 | 2017 | ||||
Stage 0 Gallbladder Cancer AJCC v8
|
56 | 0.476 | 0.800 | 3 | 9757089 | missense variant | C/G | snv | 0.27 | 0.22 | 0.020 | 1.000 | 2 | 2007 | 2009 | ||||
Stage IIA Gallbladder Cancer AJCC v8
|
56 | 0.476 | 0.800 | 3 | 9757089 | missense variant | C/G | snv | 0.27 | 0.22 | 0.020 | 1.000 | 2 | 2007 | 2009 | ||||
Stage IIB Gallbladder Cancer AJCC v8
|
56 | 0.476 | 0.800 | 3 | 9757089 | missense variant | C/G | snv | 0.27 | 0.22 | 0.020 | 1.000 | 2 | 2007 | 2009 | ||||
Stage III Gallbladder Cancer AJCC v8
|
56 | 0.476 | 0.800 | 3 | 9757089 | missense variant | C/G | snv | 0.27 | 0.22 | 0.020 | 1.000 | 2 | 2007 | 2009 | ||||
Stage IV Gallbladder Cancer AJCC v8
|
56 | 0.476 | 0.800 | 3 | 9757089 | missense variant | C/G | snv | 0.27 | 0.22 | 0.020 | 1.000 | 2 | 2007 | 2009 |